CTCL

A Mindfulness-Based Smartphone Application Intervention to Improve the Quality of Life of Patients with CTCL
CTCLDr. Nishad Sathe, Next Steps Correspondent, interviewed Lily M. Parker, second year medical student at the University of South Florida Morsani College of Medicine, to dig deeper on her research study titled “A mindfulness-based smartphone application intervention to improve the quality of life of patients with cutaneous T-cell lymphoma. A pilot/feasibility study, and an analysis of social determ …
CTCL
Bexarotene for CTCL | Therapeutic Cheat Sheet
Bexarotene for CTCLCutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL. BEXAROTENE THERAPEUTIC CHEAT SHEET Compiled by: Adrianna Gonzale …
Bexarotene for CTCL
Patient Buzz: Misdiagnosed Skin Conditions
Differential diagnosisWomen’s Health recently wrote an article about four skin conditions that are commonly misdiagnosed. Why do primary care providers sometimes misdiagnose common skin conditions? What conditions are challenging for dermatologists to diagnose? What steps can a dermatologist take to make a differential diagnosis? For expert advice, I contacted Steve Daveluy, MD, FAAD, associate professor and pr …
Differential diagnosis
Widespread Skin Necrosis Secondary to Gemcitabine Therapy
Skin Necrosis INTRODUCTION Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …
Skin Necrosis